EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Surgical Science Sweden AB's enterprise value is kr7,054.5 Mil.
Surgical Science Sweden AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was kr268.9 Mil. Therefore, Surgical Science Sweden AB's EV-to-EBITDA for today is 26.23.
The historical rank and industry rank for Surgical Science Sweden AB's EV-to-EBITDA or its related term are showing as below:
OSTO:SUS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -993.85 Med: 46.77 Max: 561.93
Current: 26.23
During the past 9 years, the highest EV-to-EBITDA of Surgical Science Sweden AB was 561.93. The lowest was -993.85. And the median was 46.77.
OSTO:SUS's EV-to-EBITDA is ranked worse than 82.17% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.19
vs OSTO:SUS: 26.23
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Surgical Science Sweden AB's stock price is kr149.90.
Surgical Science Sweden AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was kr4.590. Therefore, Surgical Science Sweden AB's PE Ratio for today is 32.66.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Surgical Science Sweden AB EV-to-EBITDA Historical Data
The historical data trend for Surgical Science Sweden AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Surgical Science Sweden AB's EV-to-EBITDA
For the Health Information Services subindustry, Surgical Science Sweden AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's EV-to-EBITDA falls into.
Surgical Science Sweden AB EV-to-EBITDA Calculation
Surgical Science Sweden AB's EV-to-EBITDA for today is calculated as:
Surgical Science Sweden AB's current Enterprise Value is kr7,054.5 Mil.
Surgical Science Sweden AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr268.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB (OSTO:SUS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Surgical Science Sweden AB's PE Ratio for today is calculated as:
Surgical Science Sweden AB's share price for today is kr149.90.
Surgical Science Sweden AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.590.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Surgical Science Sweden AB EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of Surgical Science Sweden AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Surgical Science Sweden AB (OSTO:SUS) Business Description
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments; Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations, prior to entering the clinical environment and also support and services, and Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments and also simulators for medical device companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:SUS has been successfully added to your 